Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma
- PMID: 528568
- PMCID: PMC12252948
- DOI: 10.1007/BF00410649
Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma
Abstract
A 55-year-old white woman received chemotherapy with DTIC after surgery for malignant melanoma (stage I, SSM IV, depth of invasion 12 mm). She died suddenly during the second treatment cycle. Autopsy revealed massive necrosis of the liver and thrombosis of the hepatic veins. The cause of the fatal outcome is attributed to the adverse toxic effects of DTIC.
References
-
- Baird, G.M., Willoughby, M.L.N.: Photodegradation of dacarbazine. Lancet 1978/23, 681 - PubMed
-
- Costanza, M.E., Nathanson, L., Schoenfeld, D., Wolter, J., Colsky, J., Regelson, W, Cunningham, T., Sedransk, N.: Results with methyl-CCNU and DTIC in metastatic melanoma. Cancer 40, 1010–1015 (1977) - PubMed
-
- Griner, P.F., Elbadawi, A., Packman, C.H.: Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases. Ann. Intern. Med. 85, 578–582 (1976) - PubMed
-
- Johnson, R.O., Metter, G., Wilson, W., Hill, G., Krementz, E.: Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the central oncology group. Cancer Treatm. Rep. 60, 183–187 (1976) - PubMed
-
- Lehrner, L.M., Enck, R.E.: Hepatic vein thrombosis after chemotherapy for histiocytoma. Ann. Intern. Med. 88, 575–576 (1978) - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources